Facebook Linkedin RSS Twitter Youtube
Home 2023

Ligand Pharmaceuticals

BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger
Bioprocessing

BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger

Influenza and Coronavirus Demise Could Lie with Phage Nanoparticles
Coronavirus

Influenza and Coronavirus Demise Could Lie with Phage Nanoparticles

The OmniAb® Platform: Human Sequence Antibodies from Mouse, Rat and Chicken
OMICs

The OmniAb® Platform: Human Sequence Antibodies from Mouse, Rat and Chicken

Accelerating the Discovery of Therapeutic Antibodies Using High Throughput SPR
Featured

Accelerating the Discovery of Therapeutic Antibodies Using High Throughput SPR

Advertorial: Gene Engineered Rats and Mice for Mono- and Bi-Specific Human Ab Generation
Sponsored

Advertorial: Gene Engineered Rats and Mice for Mono- and Bi-Specific Human Ab Generation

Advertorial: OmniAb
Sponsored

Advertorial: OmniAb

Ligand Licenses Four Programs to Seelos Therapeutics
Drug Discovery

Ligand Licenses Four Programs to Seelos Therapeutics

Ligand to Acquire OMT for $178 Million
Drug Discovery

Ligand to Acquire OMT for $178 Million

Ligand Buys Another 15 Biologics Programs from Selexis for $4M
Bioprocessing

Ligand Buys Another 15 Biologics Programs from Selexis for $4M

Ligand Adds “Shots-on-Goal” with Avion Pharma Collaboration
News

Ligand Adds “Shots-on-Goal” with Avion Pharma Collaboration

1234Page 1 of 4
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.